Irvine, United States
Seragon Pharmaceuticals is a dynamic player in the biotech sector, leveraging cutting-edge science to redefine health care with innovative products aimed at both humans and animals. Established in 2013 and headquartered in the United States, the company is spearheaded by a team of dedicated scientists whose mission is encapsulated in their slogan: "Research-based biopharmaceutical company dedicated to improving human and animal health through innovative science."
The company's extensive product line benefits from an integration of expertise across clinical, biomedical, and research spectrums, reflecting a solid foundation in biomedical innovation. Their state-of-the-art facilities in Irvine, CA support ongoing research and partnerships, making them a notable collaborator in the industry.
Backed by a strong $30.00M Series A investment received on 16 October 2013 from prominent investors like OrbiMed, The Column Group, Aisling Capital, VenBio Partners, and Topspin Medical, Seragon Pharmaceuticals is positioned for sustained growth. Their focus spans key areas such as Longevity, Metabolism, Gene Therapy, and Immunology, with a strong emphasis on ethical practices and consumer-driven health care solutions.
